参考文献/References:
[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimatesof incidence and mortality worldwide for 36 cancers in185 countries[J]. CA-A Cancer Journal for Clinicians,2018, 68(6): 394-424.
[2] 李功娟, 张治洋, 樊阳阳.FEZF1-AS1 在子宫内膜癌中的表达及其与患者临床特征的相关性[J]. 现代检验医学杂志,2021,36(1):77-80.LI Gongjuan,ZHANG Zhiyang,FAN Yangyang. Expressionof FEZF1-AS1 in endometrial carcinomaand its correlation with clinical characteristics ofpatients[J]. Journal of Modern Laboratory Medicine,2021,36(1):77-80.
[3] LEE B W, JEON B S, YOON B. Exogenous recombinanthuman thioredoxin-1 prevents acetaminophen-inducedliver injury by scavenging oxidative stressors,restoring the thioredoxin-1 system and inhibiting receptorinteracting protein-3 overexpression[J]. Journal ofApplied Toxicology , 2018, 38(7): 1008-1017.
[4] 余纪会, 赵文苹, 陈容, 等. 硫氧还蛋白1、触珠蛋白在非小细胞肺癌患者血清中的表达及临床意义[J]. 现代肿瘤医学,2021,29(2):238-242.YU Jihui,ZHAO Wenping,CHEN Rong,et al.Expression and clinical significance of thioredoxin1 and haptoglobin in serum of patients with nonsmallcell lung cancer [J]. Journal of ModernOncology,2021,29(2):238-242.
[5] WEN Chuangyu, WANG Huihui, WU Xiaobin, etal. ROS-mediated inactivation of the PI3K/AKTpathway is involved in the antigastric cancer effectsof thioredoxin reductase-1 inhibitor chaetocin[J]. CellDeath & Disease, 2019, 10(11): 809.
[6] PARK J W, LEE S H, WOO G H, et al. Downregulationof TXNIP leads to high proliferative activityand estrogen-dependent cell growth in breastcancer[J]. Biochemical and Biophysical ResearchCommunications, 2018, 498(3): 566-572.
[7] HORIE K, MIKAMI T, YOSHIDA T, et al. Peroxiredoxin1 expression in active ulcerative colitis mucosaidentified by proteome analysis and involvement of thioredoxinbased on immunohistochemistry[J]. OncologyLetters, 2018, 15(2): 2364-2372.
[8] 张志刚, 倪锋, 党建功, 等.CXC 趋化因子受体4 在肾透明细胞癌中的表达及临床意义[J]. 中华泌尿外科杂志,2017,38(2):88-91.ZHANG Zhigang,NI Feng,DANG Jiangong,et al.Expression of CXC chemokine receptor 4 in clearcell renal cell carcinoma [J]. Chinese Journal ofUrology,2017,38(2):88-91.
[9] 谢鸣, 高磊, 潘铁军.C-MYC 和硫氧还蛋白相互作用蛋白在前列腺癌组织的表达及临床意义[J]. 中华实验外科杂志,2019,36(2):340-342.XIE Ming,GAO Lei,PAN Tiejun. Expression andsignificance of C-MYC and thioredoxin-interactingprotein in prostate cancer [J]. Chinese Journal ofExperimental Surgery,2019,36(2):340-342.
[10] TESTA U, PELOSI E, CASTELLI G. Colorectal cancer:genetic abnormalities, tumor progression, tumorheterogeneity, clonal evolution and tumor-initiatingcells[J]. Medical Sciences (Basel, Switzerland), 2018,6(2): 31.
[11] SIEGEL R L, MILLER K D, FEDEWA S A, et al.Colorectal cancer statistics, 2017[J]. CA-A CancerJournal for Clinicians, 2017, 67(3): 177-193.
[12] HALILOVIC E, RASIC I, SOFIC A, et al. The importanceof determining preoperative serum concentrationof carbohydrate antigen 19-9 and carcinoembryonicantigen in assessing the progression of colorectal cancer[J]. Medical Archives (Sarajevo, Bosnia and Herzegovina),2020, 74(5): 346-349.
[13] 杨荟敏, 邢素倩, 白晓旭, 等. 硫氧还蛋白-1 减弱脂连蛋白对小鼠移植性肝癌生长的抑制作用[J]. 中国生物化学与分子生物学报,2017,33(9):900-907.YANG Huimin,XING Suqian,BAI Xiaoxu,et al.Thioredoxin 1 alleviates the inhibitory effect ofAPN on mouse grafted hepatocellular carcinoma[J]. Chinese Journal of Biochemistry and MolecularBiology,2017,33(9):900-907.
[14] 潘涛. 远端胃癌根治术术后复发转移与硫氧化还原蛋白-1 表达的关系[J]. 医学临床研究,2018,35(2):251-253.PAN Tao. Relationship between recurrence andmetastasis and expression of thioredoxin -1 after radicalresection of distal gastric cancer [J]. Journal of ClinicalResearch,2018,35(2):251-253.
[15] ZUO Zhigui, ZHANG Peili, LIN Feiyan, et al. Interplaybetween Trx-1 and S100P promotes colorectal cancercell epithelial-mesenchymal transition by up-regulatingS100A4 through AKT activation[J]. Journal of cellularand molecular medicine, 2018, 22(4): 2430-2441.
[16] WANG Wenqi, FANG Daoquan, ZHANG Hao, etal. Sodium butyrate selectively kills cancer cells andinhibits migration in colorectal cancer by targeting thioredoxin-1.[J]. Onco Targets and Therapy, 2020, 13 :4691-4704.
[17] WANG Fule, LIN Feiyan, ZHANG Peili, et al.Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyldisulfide, inhibits the growth, migration and invasion ofcolorectal cancer cell lines[J]. Oncology Reports, 2015,33(2): 967-973.
[18] CHO M J, YOON S J, KIM W, et al. Oxidative stressmediatedTXNIP loss causes RPE dysfunction[J].Experimental & Molecular Medicine, 2019, 51(10): 1-13.
[19] LIN Feiyan, ZHANG Peili, ZUO Zhigui, et al.Thioredoxin-1 promotes colorectal cancer invasion andmetastasis through crosstalk with S100P[J]. CancerLetters, 2017, 401: 1-10.
[20] 莫与琳, 杨亚军, 崔燎.TXNIP 介导的氧化应激在疾病中的作用机制[J].中国药理学通报,2018,34(1):16-19.MO Yulin,YANG Yajun,CUI Liao. Action andmechanism of oxidative stress mediated by TXNIPin diseases [J]. Chinese Pharmacological Bulletin,2018,34(1):16-19.
[21] KIM Y, KIM Y S, KIM M, et al. Thioredoxin-interactingprotein (TXNIP) mediates thioredoxin-dependentantioxidant mechanism in endometrial cancer cellstreated with 1α,25-dihydroxyvitamin D(3)[J]. AnticancerResearch, 2019, 39(9): 4795-4803.
相似文献/References:
[1]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer
Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(06):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[2]周秋媛,王红莉,李虹,等.NRP-1和NRP-2在结直肠癌组织中的表达水平及临床意义[J].现代检验医学杂志,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
ZHOU Qiu-yuan,WANG Hong-li,LI Hong,et al.Serum NRP-1 and NRP-2 Expression in Colorectal Cancer Patients
and Its Relationship with Clinical Pathology[J].Journal of Modern Laboratory Medicine,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
[3]史 敏,郭晓波,李思远,等.结直肠癌患者组织中K-ras和BRAF基因突变与不同病理特征的相关性分析[J].现代检验医学杂志,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
SHI Min,GUO Xiao-bo,LI Si-yuan,et al.Correlation of K-ras and BRAF Mutations with Pathological Features
in Patients with Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
[4]井丰军,倪勇.结直肠癌患者外周血NLR与RDW的变化及临床意义[J].现代检验医学杂志,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
JING Feng-jun,NI Yong.Change and Significance of Neutrophil/Lymphocyte Ratio and Red Blood
Cell Distribution Width of Peripheral Blood in the Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
[5]滕祥云,王新梦,刘 维,等.中国汉族结直肠癌患者 UGT1A1*28基因多态性分析[J].现代检验医学杂志,2019,34(06):20.[doi:10.3969 / j.issn.1671-7414.2019.06.005]
TENG Xiang-yun,WANG Xin-meng,LIU Wei,et al.Polymorphism of UGT1A1*28 Gene in Han Patients with
Colorectal Cancer in China[J].Journal of Modern Laboratory Medicine,2019,34(06):20.[doi:10.3969 / j.issn.1671-7414.2019.06.005]
[6]陈 培,邓钦木,李丹丹.血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J].现代检验医学杂志,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
CHEN Pei,DENG Qin-mu,LI Dan-dan.Diagnostic Value of Plasma Septin9 Methylation in Screening of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(06):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
[7]马胜辉,崔雪琴,李建华,等.结直肠癌组织miR-485-5p,miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究[J].现代检验医学杂志,2022,37(03):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
MA Sheng-hui,CUI Xue-qin,LI Jian-hua,et al.Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue[J].Journal of Modern Laboratory Medicine,2022,37(06):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
[8]胡道军,史文杰,孙 敏.LncRNA NEAT1/miR-23b-3p/KLF3 轴调控结直肠癌细胞的生物学功能研究[J].现代检验医学杂志,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
HU Dao-jun,SHI Wen-jie,SUN Min.LncRNA NEAT1/miR-23b-3p/ KLF3 Axis Regulates the Biological Function of Colorectal Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(06):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
[9]冯 芬.结直肠癌组织中USP11 和PPP1CA 表达水平与临床病理的相关性研究[J].现代检验医学杂志,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
FENG Fen.Correlation between USP11 and PPP1CA Expression Levels and Clinicopathology in Colorectal Cancer Tissues[J].Journal of Modern Laboratory Medicine,2022,37(06):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
[10]郑光明,孙建华,宋秋月.结直肠癌组织中锌指蛋白139(ZNF139)的表达及临床意义研究[J].现代检验医学杂志,2022,37(04):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]
ZHENG Guang-ming,SUN Jian-hua,SONG Qiu-yue.Expression and Clinical Significance of Zinc Finger Protein 139 (ZNF139) in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2022,37(06):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]